Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2024

Dec 17, 2024

30145_dirs_2024-12-17_3e1dee2e-fb16-4738-965b-b84c20143c81.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2024-12-15

Reporting Person: Felter John-Paul W. (SVP, Chief Accting Off & Cont.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-15 Humana Common F 49 $271.675 Disposed 811 Direct
2024-12-15 Humana Common M 114 Acquired 925 Direct
2024-12-15 Humana Common F 34 $271.675 Disposed 891 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-15 Restricted Stock Units $ M 114 Disposed Humana Common (114) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Humana Common (211) 211 Direct

Footnotes

F1: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

F3: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F4: Includes 327 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F5: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/24.